Cooper Companies (NASDAQ:COO – Get Free Report) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 4.580-4.660 for the period, compared to the consensus estimate of 4.620. The company issued revenue guidance of $4.3 billion-$4.3 billion, compared to the consensus revenue estimate of $4.3 billion.
Analyst Ratings Changes
A number of research analysts have recently weighed in on the stock. Needham & Company LLC dropped their price objective on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research note on Friday. Barclays raised their price objective on shares of Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a research note on Friday, March 6th. KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a research note on Friday. Robert W. Baird lowered their target price on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a research note on Friday. Finally, Rothschild & Co Redburn cut shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 target price for the company. in a research note on Wednesday, March 4th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $82.64.
Read Our Latest Research Report on Cooper Companies
Cooper Companies Stock Up 8.6%
Cooper Companies (NASDAQ:COO – Get Free Report) last released its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.85%. The firm had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.06 billion. During the same period in the previous year, the company earned $0.96 EPS. Cooper Companies’s revenue for the quarter was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, sell-side analysts expect that Cooper Companies will post 4.62 EPS for the current year.
Cooper Companies News Summary
Here are the key news stories impacting Cooper Companies this week:
- Positive Sentiment: Cooper Companies posted better-than-expected Q2 results, with EPS of $1.21 topping estimates of $1.10 and revenue of $1.08 billion beating forecasts, while sales rose 7.9% year over year. CooperCompanies Announces Second Quarter 2026 Results
- Positive Sentiment: Management said it reached agreements to resolve substantially all claims tied to the prior fertility media recall, reducing a major legal overhang and supporting investor confidence in the company’s outlook. QuiverQuant article
- Positive Sentiment: Needham reaffirmed a Buy rating on COO and lowered its price target to $86, still implying meaningful upside from current levels. TipRanks analyst update
- Positive Sentiment: Stifel, Baird, and JPMorgan all cut price targets but kept constructive ratings, suggesting analysts see the report as solid even after valuation resets. Benzinga analyst update
- Neutral Sentiment: The company guided FY2026 EPS to $4.58-$4.66, slightly around consensus, which helps confirm expectations but does not point to a major near-term surprise. Earnings report transcript
- Negative Sentiment: JPMorgan lowered its price target on COO from $80 to $71 and kept a Neutral rating, reflecting more cautious expectations despite the stock’s recent strength. JPMorgan price target update
Institutional Trading of Cooper Companies
Several institutional investors have recently made changes to their positions in COO. CYBER HORNET ETFs LLC purchased a new stake in shares of Cooper Companies during the 2nd quarter valued at $36,000. MUFG Securities EMEA plc purchased a new stake in shares of Cooper Companies during the 2nd quarter valued at $42,000. IFP Advisors Inc grew its stake in shares of Cooper Companies by 2,647.8% during the 3rd quarter. IFP Advisors Inc now owns 632 shares of the medical device company’s stock valued at $43,000 after buying an additional 609 shares during the period. Johnson Financial Group Inc. purchased a new stake in shares of Cooper Companies during the 3rd quarter valued at $59,000. Finally, Quarry LP purchased a new stake in shares of Cooper Companies during the 4th quarter valued at $70,000. 24.39% of the stock is owned by hedge funds and other institutional investors.
About Cooper Companies
Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.
The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.
Further Reading
- Five stocks we like better than Cooper Companies
- MarketBeat Week in Review – 06/01 – 06/05
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.
